Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 1
2006 2
2007 6
2008 5
2009 1
2010 2
2011 4
2012 3
2013 2
2014 7
2015 6
2016 1
2017 11
2018 14
2019 11
2020 31
2021 33
2022 25
2023 38
2024 37
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Results by year

Filters applied: . Clear all
Page 1
Antibiotic-induced gut microbiome perturbation alters the immune responses to the rabies vaccine.
Feng Y, de Jong SE, Oliveira APBN, Samaha H, Yang F, Hu M, Wang Y, Beydoun N, Xie X, Zhang H, Kazmin D, Fang Z, Zou J, Gewirtz AT, Boyd SD, Hagan T, Rouphael N, Pulendran B. Feng Y, et al. Among authors: rouphael n. Cell Host Microbe. 2025 Apr 15:S1931-3128(25)00126-X. doi: 10.1016/j.chom.2025.03.015. Online ahead of print. Cell Host Microbe. 2025. PMID: 40252648
Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection.
Morris AB, Adelman MW, Bennion KB, Martinez CD, McCook KM, Woodworth MH, Langelier CR, Rouphael N, Scharer CD, Maier CL, Kraft CS, Ford ML. Morris AB, et al. Among authors: rouphael n. JCI Insight. 2025 Apr 8;10(7):e186259. doi: 10.1172/jci.insight.186259. JCI Insight. 2025. PMID: 40197366 Free PMC article.
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients.
Hu M, Oliveira APBN, Fang Z, Feng Y, Miranda M, Kowli S, Arunachalam PS, Vasudevan G, Hui HS, Grifoni A, Sette A, Litvack M, Rouphael N, Suthar MS, Ji X, Maecker HT, Hagan T, Dhillon G, Nicolls MR, Pulendran B. Hu M, et al. Among authors: rouphael n. Cell Rep Med. 2025 Apr 15;6(4):102050. doi: 10.1016/j.xcrm.2025.102050. Epub 2025 Apr 4. Cell Rep Med. 2025. PMID: 40187358 Free PMC article.
A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone® or Flublok®) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age.
Hegmann TE, Walter EB, Smith MJ, Campbell J, El Sahly HM, Whitaker JA, Creech CB, Ustyugova IV, Goncalvez AP, Pandey A, Alefantis T, Sridhar S, Honda-Okubo Y, Petrovsky N, Frey SE, Abate G, Paulsen G, Anderson EJ, Rostad CA, Rouphael N, Makhene M, Roberts PC, Tuyishimire B, Bryant C, Winokur P. Hegmann TE, et al. Among authors: rouphael n. Vaccine. 2025 Apr 30;54:126991. doi: 10.1016/j.vaccine.2025.126991. Epub 2025 Mar 18. Vaccine. 2025. PMID: 40107003 Clinical Trial.
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.
Jayavelu ND, Samaha H, Wimalasena ST, Hoch A, Gygi JP, Gabernet G, Ozonoff A, Liu S, Milliren CE, Levy O, Baden LR, Melamed E, Ehrlich LIR, McComsey GA, Sekaly RP, Cairns CB, Haddad EK, Schaenman J, Shaw AC, Hafler DA, Montgomery RR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Higuita NIA, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Geng LN, Sesma AF, Simon V, Krammer F, Kraft M, Bime C, Calfee CS, Erle DJ, Langelier CR; IMPACC Network; Guan L, Maecker HT, Peters B, Kleinstein SH, Reed EF, Diray-Arce J, Rouphael N, Altman MC. Jayavelu ND, et al. Among authors: rouphael n. medRxiv [Preprint]. 2025 Feb 13:2025.02.12.25322164. doi: 10.1101/2025.02.12.25322164. medRxiv. 2025. PMID: 39990570 Free PMC article. Preprint.
Identification of a multi-omics factor predictive of long COVID in the IMPACC study.
Gabernet G, Maciuch J, Gygi JP, Moore JF, Hoch A, Syphurs C, Chu T, Jayavelu ND, Corry DB, Kheradmand F, Baden LR, Sekaly RP, McComsey GA, Haddad EK, Cairns CB, Rouphael N, Fernandez-Sesma A, Simon V, Metcalf JP, Agudelo Higuita NI, Hough CL, Messer WB, Davis MM, Nadeau KC, Pulendran B, Kraft M, Bime C, Reed EF, Schaenman J, Erle DJ, Calfee CS, Atkinson MA, Brackenridge SC, Melamed E, Shaw AC, Hafler DA, Ozonoff A, Bosinger SE, Eckalbar W, Maecker HT, Kim-Schulze S, Steen H, Krammer F, Westendorf K; IMPACC Network; Peters B, Fourati S, Altman MC, Levy O, Smolen KK, Montgomery RR, Diray-Arce J, Kleinstein SH, Guan L, Ehrlich LIR. Gabernet G, et al. Among authors: rouphael n. bioRxiv [Preprint]. 2025 Feb 14:2025.02.12.637926. doi: 10.1101/2025.02.12.637926. bioRxiv. 2025. PMID: 39990442 Free PMC article. Preprint.
The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant.
Suthar MS, Manning KE, Ellis ML, Jain S, Bechnak K, Vander Velden J, Laboune F, Henry AR, Godbole S, Kim S, Sahoo MK, Paredes I, Dib SM, Kalash S, Radi C, Hicks H, Tamin A, Gardner M, Bowen N, Cook P, Paden C, Harcourt J, Pinsky BA, Douek DC, Rouphael N, Moreno A. Suthar MS, et al. Among authors: rouphael n. Lancet Infect Dis. 2025 Mar;25(3):e122-e123. doi: 10.1016/S1473-3099(25)00007-6. Epub 2025 Jan 31. Lancet Infect Dis. 2025. PMID: 39900094 No abstract available.
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.
Zhang B, Fong Y, Dang L, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Graciaa DS, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Busch S, Benkeser D, Netzl A, Smith DJ, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Gilbert PB, Follmann D; Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team. Zhang B, et al. Among authors: rouphael ng. Nat Commun. 2025 Jan 17;16(1):759. doi: 10.1038/s41467-025-55931-w. Nat Commun. 2025. PMID: 39824819 Free PMC article. Clinical Trial.
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients.
Pickering H, Schaenman J, Phan HV, Maguire C, Tsitsiklis A, Rouphael N, Higuita NIA, Atkinson MA, Brakenridge S, Fung M, Messer W; IMPACC Network; Salehi-Rad R, Altman MC, Becker PM, Bosinger SE, Eckalbar W, Hoch A, Doni Jayavelu N, Kim-Schulze S, Jenkins M, Kleinstein SH, Krammer F, Maecker HT, Ozonoff A, Diray-Arce J, Shaw A, Baden L, Levy O, Reed EF, Langelier CR. Pickering H, et al. Among authors: rouphael n. Nat Commun. 2025 Jan 10;16(1):586. doi: 10.1038/s41467-025-55823-z. Nat Commun. 2025. PMID: 39794319 Free PMC article.
238 results